ACHE and Alzheimer disease: Additionally, 5α-EAL (10 and 30 mg/kg per day, i.p.) significantly improves cognitive impairments of AD mice in behavioral tests including Barnes and Y-maze tests, and 5α-EAL could reduce the activity of AChE in the hippocampus and cortex of AD mice.